Anti-rheumatic in SARS-CoV-2: benefit or risk?

Título

Anti-rheumatic in SARS-CoV-2: benefit or risk?

Autor

Francesco Ferrara

Descripción

Not available

Fecha

2020

Materia

immunology, infection, SARS-CoV-2, COVID-19, Anti-rheumatic

Identificador

DOI: 10.4081/itjm.2020.1290

Fuente

Italian Journal of Medicine

Editor

PAGEPress Publications

Cobertura

Medicine

Archivos

https://socictopen.socict.org/files/to_import/pdfs/4898390.pdf

Colección

Coronavirus

Citación

Francesco Ferrara, “Anti-rheumatic in SARS-CoV-2: benefit or risk?,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/3148.

Formatos de Salida

Position: 18612 (16 views)